A novel putative receptor protein tyrosine kinase of the met family - PubMed (original) (raw)
. 1993 May;8(5):1195-202.
Affiliations
- PMID: 8386824
A novel putative receptor protein tyrosine kinase of the met family
C Ronsin et al. Oncogene. 1993 May.
Abstract
By successive screenings of cDNA libraries prepared from human tumours and from human foreskin keratinocytes, we have isolated overlapping cDNAs coding for a novel protein which we call Ron, with sequence characteristics of a receptor protein tyrosine kinase. Ron is a 1400 amino acid protein structurally similar to the 1408 amino acid product of the C-MET proto-oncogene, the receptor for hepatocyte growth factor and scatter factor. The two proteins have 63% overall sequence identity in their intracellular regions. We have localised the RON gene to human chromosome region 3p21, a region frequently deleted in small cell carcinoma of the lung and in renal cell carcinoma, and which is believed to harbour unidentified tumour suppressor genes. Interestingly, normal lung tissue contains transcripts of the RON gene.
Similar articles
- Molecular cloning of the cDNA encoding a receptor tyrosine kinase-related molecule with a catalytic region homologous to c-met.
Paul SR, Merberg D, Finnerty H, Morris GE, Morris JC, Jones SS, Kriz R, Turner KJ, Wood CR. Paul SR, et al. Int J Cell Cloning. 1992 Sep;10(5):309-14. doi: 10.1002/stem.5530100509. Int J Cell Cloning. 1992. PMID: 1333503 - Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).
Mondino A, Giordano S, Comoglio PM. Mondino A, et al. Mol Cell Biol. 1991 Dec;11(12):6084-92. doi: 10.1128/mcb.11.12.6084-6092.1991. Mol Cell Biol. 1991. PMID: 1658624 Free PMC article. - The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor.
Huff JL, Jelinek MA, Borgman CA, Lansing TJ, Parsons JT. Huff JL, et al. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6140-4. doi: 10.1073/pnas.90.13.6140. Proc Natl Acad Sci U S A. 1993. PMID: 8392188 Free PMC article. - Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met.
Weidner KM, Hartmann G, Sachs M, Birchmeier W. Weidner KM, et al. Am J Respir Cell Mol Biol. 1993 Mar;8(3):229-37. doi: 10.1165/ajrcmb/8.3.229. Am J Respir Cell Mol Biol. 1993. PMID: 8383506 Review. - Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S. Shibuya M, et al. Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review.
Cited by
- Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
Yao HP, Feng L, Suthe SR, Chen LH, Weng TH, Hu CY, Jun ES, Wu ZG, Wang WL, Kim SC, Tong XM, Wang MH. Yao HP, et al. J Immunother Cancer. 2019 Mar 14;7(1):75. doi: 10.1186/s40425-019-0525-0. J Immunother Cancer. 2019. PMID: 30871619 Free PMC article. - The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies.
Kang CM, Babicky ML, Lowy AM. Kang CM, et al. Pancreas. 2014 Mar;43(2):183-9. doi: 10.1097/MPA.0000000000000088. Pancreas. 2014. PMID: 24518495 Free PMC article. Review. - State of the structure address on MET receptor activation by HGF.
Linossi EM, Estevam GO, Oshima M, Fraser JS, Collisson EA, Jura N. Linossi EM, et al. Biochem Soc Trans. 2021 Apr 30;49(2):645-661. doi: 10.1042/BST20200394. Biochem Soc Trans. 2021. PMID: 33860789 Free PMC article. Review. - Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair.
Huh CG, Factor VM, Sánchez A, Uchida K, Conner EA, Thorgeirsson SS. Huh CG, et al. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4477-82. doi: 10.1073/pnas.0306068101. Proc Natl Acad Sci U S A. 2004. PMID: 15070743 Free PMC article. - Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.
Beauvais DM, Nelson SE, Adams KM, Stueven NA, Jung O, Rapraeger AC. Beauvais DM, et al. J Biol Chem. 2022 Jun;298(6):102029. doi: 10.1016/j.jbc.2022.102029. Epub 2022 May 13. J Biol Chem. 2022. PMID: 35569509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous